Newer Lung Cancer Drug Alone Beats Older Combination Therapy in Real-World Study
A large real-world study in China found that third-generation EGFR inhibitor monotherapy extended progression-free survival in advanced EGFR-mutant lung cancer ...
Tag: EGFR-mutant NSCLC
Lung Cancer Pills That Target EGFR May Quietly Weaken the Heart, Study Warns
A retrospective Chinese cohort study reports rare but serious cardiovascular toxicity, including heart failure and QTc prolongation, in patients with ...
Hidden Fibroblast Subtype Drives Lung Cancer Growth and Weakens Immunotherapy
A multimodal single-cell and spatial study has uncovered a collagen-producing fibroblast subtype enriched in EGFR-mutant non-small cell lung cancer that ...
Adding Brain Radiotherapy to Targeted Drugs Extends Survival in Lung Cancer Patients with Brain Metastases
A multicenter real-world study of 465 patients found that adding brain radiotherapy to first-line third-generation EGFR inhibitors improved survival in ...
Who Needs Intensive Lung Cancer Therapy? New Algorithm Aims to Match EGFR-Mutant Patients to the Right First Treatment
A new review proposes a risk-adapted algorithm to help clinicians decide which patients with advanced EGFR-mutant lung cancer need intensive ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!